22h
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially ...
On April 6, having been directed by the Supreme Court, a very senior judge heading one of the nineteen tribunals, constituted by the Calcutta High Court, of retired HC judges to decide on appeals ...
In a world where music has been reduced to invisible files floating in the cloud, Silver Platters SoDo in Seattle stands as a glorious monument to the tangible joy of actually holding your music in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results